Ignite Creation Date:
2025-12-24 @ 4:38 PM
Ignite Modification Date:
2026-01-29 @ 4:29 PM
Study NCT ID:
NCT02595866
Status:
COMPLETED
Last Update Posted:
2024-08-09
First Post:
2015-11-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-03
First Submit QC Date:
None
Study First Post Date:
2015-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-05-10
Results First Submit QC Date:
None
Results First Post Date:
2024-07-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-16
Last Update Post Date:
2024-08-09
Last Update Post Date Type:
ACTUAL